Limba
Romanian
Romanian
English|
Obinutuzumab (anti-CD20), 1mg*5
6.521,20 RON
SKU
SKM_A2023_1mg*5
Obinutuzumab (anti-CD20) (Gazyva, GA101, Gazyvaro, Afutuzumab) is a novel, type II, glycoengineered, humanized anti-CD20monoclonal antibody that has been developed for lymphocytic leukemia and lymphoma of B-cell origin. MW : 146.1 kD.
| Price | 5.480,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
Obinutuzumab (anti-CD20) (Gazyva, GA101, Gazyvaro, Afutuzumab) is a novel, type II, glycoengineered, humanized anti-CD20monoclonal antibody that has been developed for lymphocytic leukemia and lymphoma of B-cell origin. MW : 146.1 kD. |
